The Controlled Trial of Apremilast for Rheumatoid Arthritis Treatment (CARAT)

Summary

The purpose of this study is to compare the effects of apremilast with a placebo (an inactive substance that looks like apremilast) on you and other people with rheumatoid arthritis. The investigators will be collecting information in this study to help us determine - * the safety of apremilast in patients with active rheumatoid arthritis * how long it takes for patients with active rheumatoid arthritis to respond to apremilast * how long the effects of apremilast last after the treatment has ended.

Timeline

Start

2010-05

Primary completion

2014-06

Completion

2014-06

Drugs

Indications